688065.SS Stock Analysis
68
Avoid
Based on Eyestock quantitative analysis, 688065.SS`s fundamental data and valuation indicate an investment grade of Avoid at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Undervalued
Market cap $B
2.99
Dividend yield
0.48 %
Shares outstanding
582.63 B
Cathay Biotech Inc. engages in the research and development, production and sales of new bio-based materials. The company is headquartered in Shanghai, Shanghai and currently employs 2,035 full-time employees. The company went IPO on 2020-08-12. The firm's primary products are biological long-chain dibasic acids and bio-based polyamide series, including lauric acid and brazilian acid, which are used in long-chain polyamides, fragrances, hot melt adhesives, lubricants, powder coatings and other areas. The firm sells its products to domestic and overseas markets.